CVS CFO granted options and RSUs
CVS Health EVP and CFO Brian Newman received new equity awards.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CVS Health EVP and CFO Brian Newman received new equity awards. He was granted stock options for 125,748 shares of common stock at an exercise price of $71.82 per share, which become exercisable in three equal annual installments starting on March 31, 2027.
Newman also received 19,493 restricted stock units of common stock at a reference price of $71.82 per share. These RSUs vest in three equal installments beginning on March 31, 2027. Following the RSU grant, he directly holds 41,354 shares of CVS Health common stock.
Insider Trade Summary
Grant/Award: 145,241 shares
Grant/Award
2 txns
Insider
Newman Brian
Role
EVP, Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 125,748 | $71.82 | $9.03M |
| Grant/Award | Common Stock (RSUs) | 19,493 | $71.82 | $1.40M |
Holdings After Transaction:
Stock Option — 125,748 contracts (Direct);
Common Stock (RSUs) — 41,354 shares (Direct)
Holdings Before and After:
Stock Option, 0 to 125,748 contracts (Direct);
Common Stock (RSUs), 21,861 to 41,354 shares (Direct)
Footnotes (2)
- F1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
- F2. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Key Figures
Stock options granted: 125,748 shares
Option exercise price: $71.82 per share
RSUs granted: 19,493 shares
+3 more
6 metrics
Stock options granted
125,748 shares
Option award on March 31, 2026
Option exercise price
$71.82 per share
Exercise price for 125,748 options
RSUs granted
19,493 shares
Restricted stock units awarded March 31, 2026
Post-grant common shares
41,354 shares
Direct CVS common stock holding after RSU grant
Option vesting start
March 31, 2027
First of three annual installments
Option expiration
March 31, 2036
Expiration date for granted options
Key Terms
restricted stock units, 2017 Incentive Compensation Plan, Stock Option, exercise price, +1 more
5 terms
restricted stock units financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2017 Incentive Compensation Plan financial
"awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Stock Option financial
"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "71.8200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-03-31T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did CVS (CVS) CFO Brian Newman receive in this Form 4?
Brian Newman received a grant of stock options and restricted stock units. The option covers 125,748 shares at $71.82, and 19,493 RSUs reference the same price, providing both long-term incentive and potential ownership alignment with shareholders over time.
What is the exercise price and vesting schedule of Brian Newman’s new CVS stock options?
The stock options have an exercise price of $71.82 per share and cover 125,748 shares. They become exercisable in three equal annual installments, starting on March 31, 2027, which spreads Newman's potential share purchases over several years.
How do Brian Newman’s new CVS restricted stock units vest?
Newman’s 19,493 restricted stock units vest in three equal installments. The restrictions begin to lapse on March 31, 2027, under CVS Health’s 2017 Incentive Compensation Plan, linking his realized share ownership to ongoing service and future company performance.
Are Brian Newman’s CVS equity awards part of an incentive compensation plan?
Yes, the restricted stock units were awarded under CVS Health’s 2017 Incentive Compensation Plan. This plan is designed to grant equity-based awards that align executive compensation with long-term shareholder interests and the company’s future performance trajectory.
AI-generated analysis. How Rhea-AI works. Not financial advice.
